"Dr Crombie brings high quality Australian and global life science commercial experience to the company, including senior management roles at Arana Therapeutics and EvoGenix Ltd. He was instrumental in driving Arana from start-up phase through an IPO and toward a $318 million cash sale within five years."
Start up to $318m sale in 5yrs is pretty good track record
Stock has been a very poor performer since the botched capital raising will be interesting to see if we get any US buying off the back of the US presentations
VHL Price at posting:
0.7¢ Sentiment: None Disclosure: Held